PT1562954E - Antagonistas de ccr1 para o tratamento da doenca desmielinzante inflamatoria i.a. - Google Patents

Antagonistas de ccr1 para o tratamento da doenca desmielinzante inflamatoria i.a.

Info

Publication number: PT1562954E
Authority: PT; Portugal
Prior art keywords: demanding; inflammatory; disease; treatment; compounds
Prior art date: 2002-11-13

Application number

PT03768852T

Other languages

English (en)

Inventor

Kenneth G Carson

Geraldine C B Harriman

Ghosh Shomir

Original Assignee

Millennium Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-13

Filing date

2003-11-12

Publication date

2006-07-31

2003-11-12 Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc

2006-07-31 Publication of PT1562954E publication Critical patent/PT1562954E/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Neurology (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PT03768852T 2002-11-13 2003-11-12 Antagonistas de ccr1 para o tratamento da doenca desmielinzante inflamatoria i.a. PT1562954E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US42594702P	2002-11-13	2002-11-13

Publications (1)

Publication Number	Publication Date
PT1562954E true PT1562954E (pt)	2006-07-31

Family

ID=32313083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT03768852T PT1562954E (pt)	2002-11-13	2003-11-12	Antagonistas de ccr1 para o tratamento da doenca desmielinzante inflamatoria i.a.

Country Status (25)

Country	Link
US (7)	US20040106639A1 (pt)
EP (2)	EP1669356B1 (pt)
JP (1)	JP4644491B2 (pt)
KR (1)	KR101109348B1 (pt)
CN (1)	CN100343257C (pt)
AR (1)	AR041942A1 (pt)
AT (2)	ATE325124T1 (pt)
AU (2)	AU2003291452A1 (pt)
BR (1)	BR0316261A (pt)
CA (1)	CA2505874C (pt)
CY (1)	CY1107985T1 (pt)
DE (2)	DE60305063T2 (pt)
DK (1)	DK1562954T3 (pt)
EA (1)	EA007748B1 (pt)
ES (2)	ES2346337T3 (pt)
HK (2)	HK1086011A1 (pt)
IL (2)	IL168384A (pt)
MX (1)	MXPA05005105A (pt)
NO (1)	NO331855B1 (pt)
PL (1)	PL211022B1 (pt)
PT (1)	PT1562954E (pt)
SI (1)	SI1562954T1 (pt)
TW (1)	TWI291467B (pt)
WO (1)	WO2004043965A1 (pt)
ZA (2)	ZA200504144B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7271176B2 (en) *	1998-09-04	2007-09-18	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use thereof
US7541365B2 (en)	2001-11-21	2009-06-02	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
TWI291467B (en)	2002-11-13	2007-12-21	Millennium Pharm Inc	CCR1 antagonists and methods of use therefor
US7838522B2 (en)	2004-11-17	2010-11-23	Ares Trading S.A.	Benzothiazole formulations and use thereof
US7960549B2 (en) *	2004-12-17	2011-06-14	Carole Neves	Solid forms of a chemokine receptor antagonist and methods of use thereof
MX2007007599A (es)	2004-12-21	2007-12-07	Serono Lab	Dervivados ciclicos de sulfonilamino y uso de los mismos.
DK1844032T3 (da)	2005-01-31	2011-10-24	Merck Serono Sa	N-hydroxyamid-derivater og deres anvendelse
BRPI0613042A2 (pt)	2005-07-15	2010-12-14	Serono Lab	inibidores de jnk para o tratamento de endometriose
KR20080044836A (ko)	2005-07-15	2008-05-21	라보라뚜와르 세로노 에스. 에이.	자궁내막증 치료용 ｊｎｋ 억제제
US8178083B2 (en)	2005-09-01	2012-05-15	Ares Trading, S.A.	Treatment of optic neuritis
US7601844B2 (en)	2006-01-27	2009-10-13	Bristol-Myers Squibb Company	Piperidinyl derivatives as modulators of chemokine receptor activity
BRPI0714811A2 (pt) *	2006-07-14	2014-02-18	Lilly Co Eli	Modulador de receptor de corticóide, seus sais, composições farmacêuticas compreendendo os mesmos e uso dos referidos compostos e sais na fabricação de medicamento
JP2010534669A (ja)	2007-07-24	2010-11-11	ブリストル−マイヤーズスクイブカンパニー	ケモカイン受容体活性のモジュレーターとしての非環式誘導体
WO2009082526A2 (en) *	2007-10-05	2009-07-02	Pharmacopeia, Inc.	Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation
WO2009073462A1 (en) *	2007-11-30	2009-06-11	Millennium Pharmaceuticals, Inc.	Process for the preparation of 5-cyclopropyl-5, 11-dihydro (1) benzoxepino (3, 4-b) -pyridin-5-ol using tmeda
US20090286823A1 (en) *	2007-12-17	2009-11-19	Millennium Pharmaceuticals Inc.	CCR1 Inhibitors useful for the treatment of multiple myeloma and other disorders
EP2231676B1 (en)	2008-01-11	2011-08-31	Eli Lilly & Company	(e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo-[a,d]-cyclohepten-5-ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid arthritis
TWI433838B (zh)	2008-06-25	2014-04-11	必治妥美雅史谷比公司	作為趨化因子受體活性調節劑之六氫吡啶衍生物
CA2852160A1 (en)	2011-10-28	2013-05-02	Galderma Research & Development	New leukocyte infiltrate markers for rosacea and uses thereof

Family Cites Families (104)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US377729A (en) *		1888-02-07		Half to phillips
DE80449C (pt)
DD80449A (pt)
GB1003292A (en)	1960-12-08	1965-09-02	Sandoz Ag	Improvements in or relating to 4-azathiaxanthene derivatives
NL279409A (pt)	1961-06-08
CH416624A (de)	1962-10-23	1966-07-15	Sandoz Ag	Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
NL132137C (pt) *	1963-04-24
FR88751E (pt)	1963-07-09	1967-06-07
GB1085405A (en)	1963-10-14	1967-10-04	Pfizer & Co C	Dibenzoxepins and dibenzthiepins
FR145F (pt)	1964-06-01
CH421138A (de)	1965-11-04	1966-09-30	Wander Ag Dr A	Verfahren zur Herstellung von Thioxanthenderivaten
US3409621A (en) *	1966-04-01	1968-11-05	Schering Corp	Piperazino-aza-dibenzo-[a, d]-cycloheptenes
US3625974A (en)	1967-04-28	1971-12-07	Fujisawa Pharmaceutical Co	Dibenzothiazepine derivatives
GB1206216A (en)	1967-07-18	1970-09-23	Pfizer & Co C	Aminopropylidene dibenzoxepine tranquilizers
NL6905642A (pt)	1968-04-12	1969-10-14
JPS4830064B1 (pt)	1968-12-23	1973-09-17
JPS4840356Y1 (pt)	1969-12-22	1973-11-27
US3770729A (en) *	1970-12-22	1973-11-06	Yoshitomi Pharmaceutical	N substituted piperidine compounds
GB1330966A (en)	1970-12-22	1973-09-19	Yoshitomi Pharmaceutical	N-substituted piperidine compounds methods for their production and pharmaceutical compositions containing them
JPS5146625Y2 (pt)	1971-03-24	1976-11-10
GB1323659A (en)	1971-04-10	1973-07-18	Yoshitomi Pharmaceutical	Piperazine derivatives methods for their production and pharmaceuticl compositions containing them
CA1010870A (en) *	1972-12-08	1977-05-24	Niels Lassen	Thiaxanthene derivative and method
US4250176A (en) *	1976-12-21	1981-02-10	Janssen Pharmaceutica N.V.	Piperazine derivatives
US4335122A (en) *	1981-03-18	1982-06-15	Hoechst-Roussel Pharmaceuticals Inc.	Dihydro-dibenzoxepines-thiepines and -morphanthridones, compositions and use
DE3326641A1 (de)	1982-07-27	1984-02-02	Basf Ag, 6700 Ludwigshafen	5,6-dihydro-11-h-morphantridin-6-one, ihre herstellung und diese enthaltende arzneimittel
US4547496A (en) *	1983-06-24	1985-10-15	Kyowa Hakko Kogyo Co., Ltd.	Antiulcer [1] benzepino[3,4-b]pyridine and compositions
ES8502099A1 (es)	1983-08-02	1984-12-16	Espanola Farma Therapeut	Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
DE3402060A1 (de) *	1984-01-21	1985-08-01	Dr. Karl Thomae Gmbh, 7950 Biberach	Substituierte 5,11-dihydro-6h-dibenz(b,e)azepin-6-one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CS236550B1 (cs)	1984-02-02	1985-05-15	Miroslav Protiva	Způsob přípravy esterů piperazinoalkanolů dibenzo(b,e)thiepinové řady a jejich solí s kyselinou maleinovou
CS236549B1 (cs)	1984-02-02	1985-05-15	Miroslav Protiva	Piperazinoalkanoly dibenzo(b,e)thiepinové řady a jejich soli s kyselinou maleinovou
CS240698B1 (cs)	1984-10-12	1986-02-13	Miroslav Protiva	Substituované ll-(piperidinoalkyl)-6,ll-dihydrodibenzo (b,e)thiepin-ll-karbonitrily
JPH0665664B2 (ja)	1985-01-18	1994-08-24	大塚製薬株式会社	モルフアントリジン誘導体
SE8500273D0 (sv) *	1985-01-22	1985-01-22	Leo Ab	Nya tricykliska foreningar, kompositioner innehallande sadana foreningar, framstellningsforfaranden och behandlingsmetoder
JPS6310784A (ja)	1986-03-03	1988-01-18	Kyowa Hakko Kogyo Co Ltd	抗アレルギー剤
WO1988000049A1 (en)	1986-06-26	1988-01-14	Kyowa Hakko Kogyo Co., Ltd.	Antiarrhythmic agent
US5089496A (en) *	1986-10-31	1992-02-18	Schering Corporation	Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
IT8721978A0 (it)	1987-09-21	1987-09-21	Angeli Inst Spa	Nuovi derivati ammidinici triciclici.
US4882351A (en) *	1987-10-14	1989-11-21	Roussel Uclaf	Tricyclic compounds
US4994463A (en) *	1987-12-14	1991-02-19	Kyowa Hakko Kogyo Co., Ltd.	Tricyclic thromboxane A2 antagonists
CA1341044C (en)	1988-04-28	2000-07-04	Frank J. Villani	Benzopyrido piperidine, piperidylidene and peperazine compounds, compositions, methods of manufacture and methods of use
US5242931A (en) *	1988-06-09	1993-09-07	Kyowa Hakko Kogyo Co., Ltd.	Tricyclic compounds as TXA2 antagonists
US4999363A (en) *	1988-06-09	1991-03-12	Kyowa Hakko Kogyo Co., Ltd.	Tricyclic compounds
DE3827093A1 (de)	1988-08-10	1990-02-15	Nattermann A & Cie	Verfahren zur herstellung von hochreinem ebselen
DE3838912A1 (de) *	1988-11-17	1990-05-23	Thomae Gmbh Dr K	Mittel zur behandlung von akuten und chronischen obstruktiven atemwegserkrankungen
JPH0694464B2 (ja) *	1991-01-23	1994-11-24	協和醗酵工業株式会社	三環式化合物およびその中間体
EP0511477B1 (en) *	1991-03-11	1996-07-10	Kyowa Hakko Kogyo Co., Ltd.	Indole derivatives
WO1992016226A1 (en)	1991-03-19	1992-10-01	Smithkline Beecham Corporation	Il-1 inhibitors
JPH06508129A (ja)	1991-05-23	1994-09-14	シェリング・コーポレーション	新規のベンゾピリドピペリジリデン化合物、組成物、製造法および使用法
AU2392392A (en)	1991-07-23	1993-02-23	Schering Corporation	Novel benzopyrido piperylidene compounds, compositions, methods of manufacture and methods of use
US5378701A (en) *	1991-12-27	1995-01-03	Kyowa Hakko Kogyo	Tricyclic compounds
US5679703A (en) *	1992-09-16	1997-10-21	Kyowa Hakko Kogyo, Co., Ltd.	Tricyclic compounds having ACAT inhibiting activity
JP3664176B2 (ja)	1992-11-10	2005-06-22	ジェネンテック・インコーポレーテッド	Ｃ−ｃｃｋｒ−１，ｃ−ｃケモカインレセプター
US5538986A (en) *	1993-12-06	1996-07-23	Schering Corporation	Tricyclic derivatives, compositions and methods of use
MY113463A (en) *	1994-01-04	2002-03-30	Novo Nordisk As	Novel heterocyclic compounds
AU5270796A (en)	1995-04-07	1996-10-23	Novo Nordisk A/S	N-substituted azaheterocyclic carboxylic acids and esters th ereof
AU5271096A (en)	1995-04-07	1996-10-23	Novo Nordisk A/S	Novel heterocyclic compounds
US5801175A (en) *	1995-04-07	1998-09-01	Schering Corporation	Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5712280A (en)	1995-04-07	1998-01-27	Schering Corporation	Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
UA54385C2 (uk) *	1995-04-07	2003-03-17	Ново Нордіск А/С	N-заміщені азагетероциклічні карбонові кислоти та їх ефіри, спосіб їх одержання, фармацевтична композиція та спосіб лікування
JPH0940662A (ja)	1995-05-24	1997-02-10	Kyowa Hakko Kogyo Co Ltd	三環式化合物
US6150355A (en) *	1995-09-13	2000-11-21	Kyowa Hakko Kogyo Co., Ltd.	Phenylpiperidine derivative
WO1997024325A1 (en)	1995-12-28	1997-07-10	Takeda Chemical Industries, Ltd.	DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS
DE29602088U1 (de)	1996-02-07	1996-04-04	Buemach Engineering Internatio	Verschraubbarer druckmittelbetätigter Arbeitszylinder mit Verschlußteilen zur Kopplung des Zylinderrohres
WO1997044329A1 (en)	1996-05-20	1997-11-27	Teijin Limited	Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
CA2259927A1 (en) *	1996-07-12	1998-01-22	Leukosite, Inc.	Chemokine receptor antagonists and methods of use therefor
US6323206B1 (en) *	1996-07-12	2001-11-27	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
WO1998004554A1 (fr)	1996-07-29	1998-02-05	Banyu Pharmaceutical Co., Ltd.	Antagonistes de recepteurs de chemokines
JP2001500507A (ja)	1996-09-13	2001-01-16	シェーリングコーポレイション	ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な新規三環式ピペリジニル化合物
CN1237176A (zh)	1996-09-13	1999-12-01	先灵公司	用作fpt抑制剂的三环化合物
IL128926A0 (en)	1996-09-13	2000-02-17	Schering Corp	Substituted benzocycloheptapyridines useful as inhibitors of farnesyl-protein transferase
SK33899A3 (en)	1996-09-13	2000-02-14	Schering Corp	Tricyclic inhibitors of farnesyl protein transferase
SK33199A3 (en)	1996-09-13	1999-12-10	Schering Corp	Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
DE69731544T2 (de)	1996-09-13	2005-10-27	Schering Corp.	Trizyklische antitumor verbindungen mit farnesyl protein transferase inhibierender wirkung
CZ87499A3 (cs)	1996-09-13	1999-08-11	Schering Corporation	Substituované deriváty benzocykloheptapyridinu použitelné při léčbě nádorových onemocnění tím, že inhibují farnesylprotein transferázu
ZA978792B (en)	1996-10-04	1998-04-06	Novo Nordisk As	N-substituted azaheterocyclic compounds.
CA2267835A1 (en)	1996-10-04	1998-04-16	Novo Nordisk A/S	1,4-disubstituted piperazines
WO1998015546A1 (en)	1996-10-04	1998-04-16	Novo Nordisk A/S	N-substituted azaheterocyclic compounds
WO1998025617A1 (en)	1996-12-13	1998-06-18	Merck & Co., Inc.	Substituted aryl piperazines as modulators of chemokine receptor activity
WO1998025605A1 (en)	1996-12-13	1998-06-18	Merck & Co., Inc.	Spiro-substituted azacycles as modulators of chemokine receptor activity
AU5604998A (en)	1996-12-13	1998-07-03	Merck & Co., Inc.	Spiro-substituted azacycles as modulators of chemokine receptor activity
US5919776A (en) *	1996-12-20	1999-07-06	Merck & Co., Inc.	Substituted aminoquinolines as modulators of chemokine receptor activity
WO1998027815A1 (en)	1996-12-20	1998-07-02	Merck & Co., Inc.	Substituted aminoquinolines as modulators of chemokine receptor activity
WO1998043638A1 (fr)	1997-03-27	1998-10-08	Kyowa Hakko Kogyo Co., Ltd.	Agent therapeutique pour maladies auto-immunes
US5877177A (en) *	1997-06-17	1999-03-02	Schering Corporation	Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US6040318A (en)	1997-06-25	2000-03-21	Novo Nordisk A/S	Tricycle substituted with azaheterocyclic carboxylic acids
JP2002515914A (ja)	1997-06-25	2002-05-28	ノボノルディスクアクティーゼルスカブ	新規へテロ環式化合物
US6048856A (en) *	1997-12-17	2000-04-11	Novo Nordisk A/S	Heterocyclic compounds
US6613905B1 (en)	1998-01-21	2003-09-02	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) *	1998-01-21	2003-01-21	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
JP2002501052A (ja)	1998-01-21	2002-01-15	ミレニアム・ファーマシューティカルズ・インコーポレイテッド	ケモカイン受容体アンタゴニストおよびその使用方法
WO1999037651A1 (en) *	1998-01-21	1999-07-29	Millenium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) *	1998-09-04	2003-01-07	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US20020169155A1 (en) *	1998-09-04	2002-11-14	Millennium Pharmaceuticals, Inc.	Chemokine receptor anagonists and methods of use therefor
US7271176B2 (en) *	1998-09-04	2007-09-18	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use thereof
AU2331199A (en)	1998-09-04	2000-03-27	Kyowa Hakko Kogyo Co. Ltd.	Chemokine receptor antagonists and methods of use therefor
WO2003045942A2 (en)	1998-09-04	2003-06-05	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use thereof
US6288083B1 (en) *	1998-09-04	2001-09-11	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
EP1135129A1 (en)	1998-12-02	2001-09-26	Novo Nordisk A/S	Use of n-substituted azaheterocyclic compounds for the manufacture of a pharmaceutical composition for the treatment of indications related to angiogenesis
WO2001009137A1 (en) *	1999-07-28	2001-02-08	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
WO2001009094A2 (en)	1999-07-28	2001-02-08	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
JP4889920B2 (ja) *	2001-11-21	2012-03-07	ミレニアムファーマシューティカルズ，インコーポレイテッド	ケモカイン受容体アンタゴニストおよびその使用方法
TWI291467B (en) *	2002-11-13	2007-12-21	Millennium Pharm Inc	CCR1 antagonists and methods of use therefor
WO2006114870A1 (ja)	2005-04-20	2006-11-02	Mitsubishi Denki Kabushiki Kaisha	過電流継電器
JP4715952B2 (ja)	2009-02-18	2011-07-06	村田機械株式会社	フロッグレッグ型移載装置

2003
- 2003-11-11 TW TW92131488A patent/TWI291467B/zh not_active IP Right Cessation
- 2003-11-12 AR ARP030104145 patent/AR041942A1/es active IP Right Grant
- 2003-11-12 JP JP2004552003A patent/JP4644491B2/ja not_active Expired - Fee Related
- 2003-11-12 AT AT03768852T patent/ATE325124T1/de active
- 2003-11-12 WO PCT/US2003/035817 patent/WO2004043965A1/en active Application Filing
- 2003-11-12 EP EP20060004508 patent/EP1669356B1/en not_active Expired - Lifetime
- 2003-11-12 EP EP20030768852 patent/EP1562954B1/en not_active Expired - Lifetime
- 2003-11-12 KR KR1020057008518A patent/KR101109348B1/ko not_active IP Right Cessation
- 2003-11-12 MX MXPA05005105A patent/MXPA05005105A/es active IP Right Grant
- 2003-11-12 SI SI200330325T patent/SI1562954T1/sl unknown
- 2003-11-12 US US10/706,835 patent/US20040106639A1/en not_active Abandoned
- 2003-11-12 AT AT06004508T patent/ATE468340T1/de not_active IP Right Cessation
- 2003-11-12 AU AU2003291452A patent/AU2003291452A1/en not_active Abandoned
- 2003-11-12 PT PT03768852T patent/PT1562954E/pt unknown
- 2003-11-12 EA EA200500803A patent/EA007748B1/ru not_active IP Right Cessation
- 2003-11-12 CN CNB2003801086866A patent/CN100343257C/zh not_active Expired - Fee Related
- 2003-11-12 DK DK03768852T patent/DK1562954T3/da active
- 2003-11-12 PL PL377715A patent/PL211022B1/pl unknown
- 2003-11-12 CA CA 2505874 patent/CA2505874C/en not_active Expired - Fee Related
- 2003-11-12 ES ES06004508T patent/ES2346337T3/es not_active Expired - Lifetime
- 2003-11-12 BR BR0316261A patent/BR0316261A/pt not_active Application Discontinuation
- 2003-11-12 DE DE2003605063 patent/DE60305063T2/de not_active Expired - Lifetime
- 2003-11-12 DE DE60332663T patent/DE60332663D1/de not_active Expired - Lifetime
- 2003-11-12 ES ES03768852T patent/ES2261979T3/es not_active Expired - Lifetime
2005
- 2005-05-04 IL IL168384A patent/IL168384A/en not_active IP Right Cessation
- 2005-05-10 NO NO20052272A patent/NO331855B1/no not_active IP Right Cessation
- 2005-05-23 ZA ZA200504144A patent/ZA200504144B/en unknown
- 2005-08-16 US US11/204,930 patent/US20050288319A1/en not_active Abandoned
- 2005-08-23 HK HK06108230A patent/HK1086011A1/xx not_active IP Right Cessation
- 2005-08-23 HK HK05107405A patent/HK1074046A1/xx not_active IP Right Cessation
2006
- 2006-07-21 CY CY061101015T patent/CY1107985T1/el unknown
- 2006-09-20 ZA ZA2006/07868A patent/ZA200607868B/en unknown
2007
- 2007-09-13 US US11/900,744 patent/US7732459B2/en not_active Expired - Fee Related
2008
- 2008-07-03 AU AU2008202965A patent/AU2008202965B2/en not_active Ceased
2010
- 2010-04-22 US US12/765,070 patent/US7977350B2/en not_active Expired - Fee Related
- 2010-12-16 IL IL210046A patent/IL210046A/en active IP Right Grant
2011
- 2011-06-02 US US13/151,701 patent/US8394817B2/en not_active Expired - Fee Related
2013
- 2013-01-22 US US13/746,688 patent/US20130289063A1/en not_active Abandoned
2014
- 2014-02-04 US US14/172,398 patent/US9334283B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE60305063D1 (de)	2006-06-08
DE60305063T2 (de)	2006-11-16
KR20050074609A (ko)	2005-07-18
CA2505874A1 (en)	2004-05-27
US20110230516A1 (en)	2011-09-22
TW200413347A (en)	2004-08-01
KR101109348B1 (ko)	2012-01-31
US7977350B2 (en)	2011-07-12
CN100343257C (zh)	2007-10-17
ATE325124T1 (de)	2006-06-15
NO331855B1 (no)	2012-04-23
TWI291467B (en)	2007-12-21
PL377715A1 (pl)	2006-02-06
US20150005338A1 (en)	2015-01-01
PL211022B1 (pl)	2012-03-30
CY1107985T1 (el)	2013-09-04
IL210046A0 (en)	2011-07-31
US7732459B2 (en)	2010-06-08
HK1074046A1 (en)	2005-10-28
EP1669356B1 (en)	2010-05-19
NO20052272L (no)	2005-06-06
US20130289063A1 (en)	2013-10-31
WO2004043965A1 (en)	2004-05-27
US20040106639A1 (en)	2004-06-03
IL210046A (en)	2015-07-30
AU2003291452A1 (en)	2004-06-03
AR041942A1 (es)	2005-06-01
CA2505874C (en)	2012-07-17
EA200500803A1 (ru)	2005-10-27
SI1562954T1 (sl)	2006-10-31
US20100249174A1 (en)	2010-09-30
ES2261979T3 (es)	2006-11-16
EP1669356A1 (en)	2006-06-14
AU2008202965A1 (en)	2008-07-31
EP1562954A1 (en)	2005-08-17
MXPA05005105A (es)	2005-07-01
US20050288319A1 (en)	2005-12-29
BR0316261A (pt)	2005-10-11
US9334283B2 (en)	2016-05-10
HK1086011A1 (en)	2006-09-08
EA007748B1 (ru)	2006-12-29
ATE468340T1 (de)	2010-06-15
JP4644491B2 (ja)	2011-03-02
JP2006508966A (ja)	2006-03-16
ZA200504144B (en)	2007-04-25
DK1562954T3 (da)	2006-08-28
IL168384A (en)	2011-01-31
ES2346337T3 (es)	2010-10-14
DE60332663D1 (de)	2010-07-01
ZA200607868B (en)	2008-01-08
AU2008202965B2 (en)	2012-03-22
CN1738824A (zh)	2006-02-22
EP1562954B1 (en)	2006-05-03
US20080139602A1 (en)	2008-06-12
US8394817B2 (en)	2013-03-12

Publication	Publication Date	Title
HK1074046A1 (en)	2005-10-28	Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory disease
ECSP055719A (es)	2005-07-06	Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos
BR0314052A (pt)	2005-07-05	Imidazolpiridinas e métodos para sua fabricação e uso
MXPA05009595A (es)	2005-11-04	Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
DE602004030222D1 (de)	2011-01-05	2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen
BR0316350A (pt)	2005-09-27	Diaminotriazóis úteis como inibidores de proteìna cinases
IL173032A0 (en)	2006-06-11	Pyridazine derivatives and their use as therapeutic agents
DE60316779D1 (de)	2007-11-22	Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
AP2004003069A0 (en)	2004-06-30	3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof.
MXPA03011484A (es)	2004-03-18	Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
NO20062983L (no)	2006-07-24	Sulfonamid-derivater for behandling av sykdommer
TNSN04165A1 (en)	2007-03-12	Substituted hydroxyethylamines
CY1112932T1 (el)	2016-04-13	Αναστολεις sμαd7 για τη θεραπευτικη αγωγη ασθενειων του κνς
DE60226729D1 (de)	2008-07-03	Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
CY1108932T1 (el)	2014-07-02	Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
ATE307810T1 (de)	2005-11-15	Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
BR0316723A (pt)	2005-10-18	Derivados de anilinopirazol úteis para o tratamento de diabetes
BR0316458A (pt)	2005-10-11	Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
CY1119257T1 (el)	2018-02-14	Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα δεξτρομεθορφανης n-meθυλ-d-ασπαρτικων (nmda)
DK1463735T3 (da)	2009-12-14	Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
BR0315462A (pt)	2005-08-23	Composto, composição farmacêutica, uso de um composto, método para o tratamento de um sujeito que sofre de uma condição patológica ou de doença susceptìvel de alìvio por antagonismo de receptores de ltd4 e produto de combinação
MXPA03011702A (es)	2004-03-19	Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias.
BR0306855A (pt)	2005-04-05	Método para o tratamento de distúrbios cognitivos
EA200100876A3 (ru)	2002-06-27	Фармацевтическая композиция для предупреждения или лечения заболевания, связанного с избыточным продуцированием il-12
DE60315597D1 (de)	2007-09-27	Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen